CD8A and neoplasm: Adenosine signaling via A2aR can not only inhibit the antitumor immune response of immune effector cells such as CD8+ T cells, NK cells, DC cells, and macrophages but also enhance the proliferation and polarization of immunosuppressive cells, thereby promoting progression of neoplasm [9–11].